Carrier Screening Market Worth $ 4.0 Billion By 2024– Exclusive Report By Marketsandmarkets™

By Author: Prachee
Total Articles: 38
Comment this article

Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024", is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72642285

Browse in-depth TOC on "Carrier Screening Market”

130– Tables

32– Figures

148 – Pages

Key Market

The major companies in the carrier screening market include Eurofins Scientific (US), Invitae (US), OPKO Health (US), Fulgent Genetics (US), Quest Diagnostics (US), Sema4 (US), Myriad Genetics (US), Illumina (US), and Thermo ...
... Fisher Scientific (US).

The expanded carrier screening segment to account for the largest share of the global carrier screening market in 2019.

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening. The expanded carrier screening segment to account for the largest share of the global carrier screening market in 2019. The largest share of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.

The hospitals segment accounted for the largest share of the market in 2018.

On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users. In 2018, hospitals formed the largest end-user segment in the carrier screening market. The growing patient population, increase in Medicare reimbursement for clinical tests performed in hospitals, and the emergence of advanced diagnostic tests are some of the key factors driving the growth of this end-user segment.

“The services segment is expected to grow at the highest CAGR during the forecast period.”

The carrier screening market is broadly segmented into two major segments—products and services. The services segment is expected to account for the largest market share in the forecast period. The high growth of this segment is attributed to the rising number of testing service providers and the growing volume of tests conducted across the globe.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=72642285

“In 2018, North America was the largest regional market for carrier screening.”

The global carrier screening market is segmented into North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW). In 2018, North America was the largest regional market for carrier screening, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=72642285

Browse Adjacent Market: 3D Bioprinting Market Research Reports & Consulting

Related Reports:

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/carrier-screening-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/carrier-screening.asp